Capital Investment Counsel Inc purchased a new stake in shares of Clorox Company (The) (NYSE:CLX) during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 2,250 shares of the company’s stock, valued at approximately $297,000.

Several other hedge funds have also recently added to or reduced their stakes in the company. Fjarde AP Fonden Fourth Swedish National Pension Fund raised its position in shares of Clorox Company (The) by 18.7% during the 3rd quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund now owns 28,206 shares of the company’s stock valued at $3,721,000 after buying an additional 4,443 shares during the period. Bank of New York Mellon Corp raised its position in shares of Clorox Company (The) by 0.7% during the 3rd quarter. Bank of New York Mellon Corp now owns 1,062,319 shares of the company’s stock valued at $140,129,000 after buying an additional 7,222 shares during the period. DekaBank Deutsche Girozentrale raised its position in shares of Clorox Company (The) by 92.2% during the 3rd quarter. DekaBank Deutsche Girozentrale now owns 87,052 shares of the company’s stock valued at $11,997,000 after buying an additional 41,771 shares during the period. Sigma Planning Corp raised its position in shares of Clorox Company (The) by 7.4% during the 3rd quarter. Sigma Planning Corp now owns 23,221 shares of the company’s stock valued at $3,063,000 after buying an additional 1,599 shares during the period. Finally, Rhumbline Advisers raised its position in shares of Clorox Company (The) by 0.9% during the 3rd quarter. Rhumbline Advisers now owns 303,865 shares of the company’s stock valued at $40,083,000 after buying an additional 2,730 shares during the period. 71.58% of the stock is currently owned by hedge funds and other institutional investors.

Clorox Company (NYSE CLX) traded up $0.23 during trading on Wednesday, reaching $135.31. 799,700 shares of the company traded hands, compared to its average volume of 817,351. Clorox Company has a 12-month low of $112.28 and a 12-month high of $141.76. The company has a debt-to-equity ratio of 3.02, a current ratio of 1.10 and a quick ratio of 0.77. The firm has a market cap of $17,417.03, a P/E ratio of 24.34, a PEG ratio of 3.68 and a beta of 0.39.

Clorox Company (The) (NYSE:CLX) last posted its earnings results on Wednesday, November 1st. The company reported $1.46 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.41 by $0.05. The firm had revenue of $1.50 billion during the quarter, compared to the consensus estimate of $1.48 billion. Clorox Company (The) had a net margin of 11.84% and a return on equity of 161.59%. The firm’s revenue for the quarter was up 4.0% on a year-over-year basis. During the same quarter last year, the firm earned $1.36 EPS. research analysts predict that Clorox Company will post 5.58 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 9th. Shareholders of record on Wednesday, January 24th will be paid a $0.84 dividend. This represents a $3.36 annualized dividend and a dividend yield of 2.48%. Clorox Company (The)’s dividend payout ratio (DPR) is 61.88%.

COPYRIGHT VIOLATION NOTICE: This story was reported by Watch List News and is owned by of Watch List News. If you are accessing this story on another domain, it was illegally stolen and republished in violation of international trademark & copyright legislation. The original version of this story can be viewed at https://www.watchlistnews.com/capital-investment-counsel-inc-takes-297000-position-in-clorox-company-the-clx/1705107.html.

In other Clorox Company (The) news, SVP Jon M. Balousek sold 9,223 shares of the business’s stock in a transaction on Wednesday, August 23rd. The shares were sold at an average price of $138.87, for a total value of $1,280,798.01. Following the completion of the transaction, the senior vice president now owns 20,614 shares in the company, valued at $2,862,666.18. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, SVP Matthew T. Laszlo sold 20,051 shares of the business’s stock in a transaction on Wednesday, November 8th. The stock was sold at an average price of $130.46, for a total transaction of $2,615,853.46. Following the completion of the transaction, the senior vice president now owns 10,896 shares of the company’s stock, valued at approximately $1,421,492.16. The disclosure for this sale can be found here. In the last 90 days, insiders sold 41,293 shares of company stock valued at $5,560,303. Insiders own 1.00% of the company’s stock.

CLX has been the topic of several analyst reports. BMO Capital Markets reaffirmed a “buy” rating and set a $150.00 price target on shares of Clorox Company (The) in a research report on Thursday, October 5th. Barclays PLC reaffirmed an “equal weight” rating and set a $136.00 price target (down previously from $140.00) on shares of Clorox Company (The) in a research report on Friday, August 4th. Morgan Stanley reduced their price target on shares of Clorox Company (The) from $138.00 to $128.00 and set an “equal weight” rating on the stock in a research report on Thursday, November 2nd. Royal Bank Of Canada reaffirmed a “hold” rating and set a $115.00 price target on shares of Clorox Company (The) in a research report on Sunday, October 8th. Finally, Jefferies Group LLC reaffirmed a “hold” rating and set a $132.00 price target (down previously from $137.00) on shares of Clorox Company (The) in a research report on Friday, October 6th. Two equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have assigned a buy rating to the company’s stock. Clorox Company (The) has an average rating of “Hold” and a consensus price target of $128.72.

Clorox Company (The) Company Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Company (The) (NYSE:CLX).

Institutional Ownership by Quarter for Clorox Company (The) (NYSE:CLX)

Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with Analyst Ratings Network's FREE daily email newsletter.